In this study, we analysed the gene expression profile of tumour biopsies from the TRastuzumab UPfront in HER2+ locally advanced BC (TRUP) window-of-opportunity trial10 before and after brief exposure to trastuzumab. Here, ERBB2 is linked to neoplasm.